CHINA TOPIX

11/22/2024 02:47:01 am

Make CT Your Homepage

cervical cancer

China Food and Drug Administration approved use of GSK HPV vaccine Cervarix.

China's FDA Approves use of GlaxoSmithKline's Cervarix Vaccine

China's Food and Drug Administration has approved the use of GlaxoSmithKline (GSK) Plc's human papillomavirus (HPV) vaccine Cervarix to help women in the country fight cervical cancer, the drug maker announced on Monday.

HPV Screening Tests Predict Cervical Cancer Better Than Pap Tests

HPV testing every three years might provide more reassurance against pre-cancer and cancer.

Real Time Analytics